ONE-YEAR RESULTS OF HALF- VERSUS STANDARD-DOSE PHOTODYNAMIC THERAPY COMBINED WITH RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

Wong Ian Y.; Shi Xuan; Gangwani Rita; Iu Lawrence P.; Fung Nicholas; Li Qing; Ng Alex L. K.; Li Xiaoxin

首页> 外文期刊>Retina >ONE-YEAR RESULTS OF HALF- VERSUS STANDARD-DOSE PHOTODYNAMIC THERAPY COMBINED WITH RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

【24h】

ONE-YEAR RESULTS OF HALF- VERSUS STANDARD-DOSE PHOTODYNAMIC THERAPY COMBINED WITH RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

机译：一年的标准剂量光动力治疗的一年结果与Ranibizumab相结合息肉瘤脉络膜病变

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To explore the efficacy of half-dose verteporfin photodynamic therapy (hd-PDT) and standard-dose photodynamic therapy (sd-PDT), when combined with ranibizumab in the treatment of polypoidal choroidal vasculopathy.

机译：目的：探讨半剂量维六氟胺光动力治疗（HD-PDT）和标准剂量光动力治疗（SD-PDT）的疗效，与Ranibizumab相结合治疗息肉脉络膜血管病变。

著录项

来源
《Retina》 |2018年第4期|共6页
作者
Wong Ian Y.; Shi Xuan; Gangwani Rita; Iu Lawrence P.; Fung Nicholas; Li Qing; Ng Alex L. K.; Li Xiaoxin;
展开▼
作者单位

Univ Hong Kong LKS Fac Med Dept Ophthalmol Hong Kong Hong Kong Peoples R China;

Peking Univ Peoples Hosp Dept Ophthalmol Beijing Peoples R China;

Univ Hong Kong LKS Fac Med Dept Ophthalmol Hong Kong Hong Kong Peoples R China;

Univ Hong Kong LKS Fac Med Dept Ophthalmol Hong Kong Hong Kong Peoples R China;

Univ Hong Kong LKS Fac Med Dept Ophthalmol Hong Kong Hong Kong Peoples R China;

Univ Hong Kong LKS Fac Med Dept Ophthalmol Hong Kong Hong Kong Peoples R China;

Univ Hong Kong LKS Fac Med Dept Ophthalmol Hong Kong Hong Kong Peoples R China;

Peking Univ Peoples Hosp Dept Ophthalmol Beijing Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
polypoidal choroidal vasculopathy; age-related macular degeneration; photodynamic therapy; verteporfin; ranibizumab; half-dose; half-fluence;

机译：息肉脉络膜血管病;年龄相关的黄斑变性;光动力疗法;verteporfin;ranibizumab;半剂量;半量;

相似文献

外文文献
中文文献
专利

1. ONE-YEAR RESULTS OF HALF- VERSUS STANDARD-DOSE PHOTODYNAMIC THERAPY COMBINED WITH RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY [J] . Wong Ian Y., Shi Xuan, Gangwani Rita, Retina . 2018,第4期

机译：一年的标准剂量光动力治疗的一年结果与Ranibizumab相结合息肉瘤脉络膜病变
2. Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy [J] . Arisa Ito, Maiko Maruyama-Inoue, Yoko Kitajima, PLoS One . 2020,第6期

机译：比较光动力疗法的一年结果与Ranibizumab或Aflibercept治疗息肉瘤脉络膜病变
3. One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy [J] . Madoka Sakurai, Takayuki Baba, Masayasu Kitahashi, Clinical ophthalmology . 2014,第9期

机译：玻璃体内雷珠单抗联合低通量光动力疗法治疗息肉样脉络膜血管病的一年结果
4. Prognostic Analysis of Polypoidal Choroidal Vasculopathy Using an Image-Based Approach [C] . Yong-Ming Chen, Wei-Yang Lin, Chia-Ling Tsai 2016 International Computer Symposium . 2016

机译：基于图像的方法对息肉样脉络膜血管病变的预后分析
5. Genetic Investigation of Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy. [D] . Liu, Ke. 2013

机译：年龄相关性黄斑变性和息肉样脉络膜血管病的遗传学研究。
6. Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy [O] . Arisa Ito, Maiko Maruyama-Inoue, Yoko Kitajima, 2020

机译：比较光动力治疗与ranibizumab或Aflibercept治疗脊髓瘤脉络膜病变的一年结果
7. Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy [O] . Arisa Ito, Maiko Maruyama-Inoue, Yoko Kitajima, 2020

机译：比较光动力治疗与ranibizumab或Aflibercept治疗脊髓瘤脉络膜病变的一年结果

ONE-YEAR RESULTS OF HALF- VERSUS STANDARD-DOSE PHOTODYNAMIC THERAPY COMBINED WITH RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

摘要

著录项

相似文献

相关主题

期刊订阅